NCT03045705

Brief Summary

In the current study the investigators wish to evaluate the effect the doctors and midwives in the delivery room have on the timing and modality of analgesia chosen by the participants. The participants will be randomly divided into 2 groups. Both groups will be advised of the different modalities of analgesia available during labor. One group will be managed in the delivery room the same as if not part of the study, meaning the doctors and midwives will treat the participants the way they usually do regarding analgesia. The second group of participants will not be asked by the doctors and midwives about analgesia at all but will be able to receive analgesia by a modality of choice at the timing of choice.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 7, 2017

Completed
2.1 years until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

1.4 years

First QC Date

February 5, 2017

Last Update Submit

September 12, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual analogue scale at the time of epidural anesthesia

    Visual analogue scale as reflected by the participant at the time of choice to receive epidural anesthesia.

    Up to 3 days from admission.

Secondary Outcomes (3)

  • Visual analogue scale at the time of first medical analgesia

    Up to 3 days from admission.

  • Analgesia during labor

    Up to 3 days from admission.

  • Cervical dilatation at the time of epidural anesthesia

    Up to 3 days from admission.

Study Arms (2)

Labor+routine pain management

ACTIVE COMPARATOR

Women that will be treated by the medical team in the delivery room as if not part of a study regarding pain management.

Behavioral: Routine pain management

Labor+experimental pain management

ACTIVE COMPARATOR

Women that will not be asked at all by the medical team in the delivery room regarding analgesia during labor but will be able to receive analgesia at wish at the time of choice.

Behavioral: No inquiry regarding analgesia

Interventions

Women that will be asked according to the routine management regarding pain management during labor, meaning frequent inquiries regarding the woman's wishes to receive analgesia by the medical team.

Labor+routine pain management

women will not be asked about analgesia during labor by the medical team, but will be able to receive the modality of choice at the time of choice.

Labor+experimental pain management

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women planned for vaginal delivery.

You may not qualify if:

  • Women planned for cesarean section.
  • Women with comorbidities related to pain that may exacerbate during labor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam health care campus

Haifa, Israel

Location

MeSH Terms

Conditions

Labor Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Roy Lauterbach, MD

    Rambam Health Care Campus

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary investigator

Study Record Dates

First Submitted

February 5, 2017

First Posted

February 7, 2017

Study Start

March 1, 2019

Primary Completion

July 31, 2020

Study Completion

September 1, 2020

Last Updated

September 16, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations